Ascendancy Of Medical Cannabis And Opposition From Major Pharmaceuticals

Over the years, medical marijuana has began an ascendancy as the most suitable therapy for a wide range of medical conditions with significantly lower risks when compared to the use of pills and conventional prescription drugs. Unfortunately, medical marijuana has been demonized by the media and constantly faces a lot of opposition from many industries that are directly threatened by the increasing popularity and relevance of the natural therapy. Awareness on the relevance and applicability of marijuana has directly affected the earnings of very many industries such as the tobacco industry providing a healthier alternative to smoking tobacco, the alcohol industry, textile and mostly affected is the pharmaceutical industry with staggering impact on her profit earnings.

With significant advancement in scientific research on the properties and uses of cannabis, the discovery of CBD(one of the chemical compounds of cannabis) has radically supplanted preexisting misconceptions about the benefits and uses of cannabis with tremendous therapeutic and medical benefits. Typically, cannabis plant contains both Cannabidiol(CBD) and tetrahydrocannabinol (THC) as the major compounds. However, medical marijuana contains significantly higher CBD and relatively lesser or almost none THC making it safer and not psychoactive as opposed to the deceptions that are constantly popularized by major pharmaceutical propaganda.

Undoubtedly, medical marijuana has provided safer and cheaper treatment options to people suffering from depression while reducing side effects associated with prescription drugs. Similarly, medical marijuana is an effective treatment option for anxiety disorders and insomnia, a suitable alternative to painkillers and a wide range of medical conditions with a host of other therapeutic benefits. Regardless of the numerous advantages and uses of medical marijuana, it continues to face stiff opposition from major pharmaceuticals that make staggering profits from the sales of prescription medications.

In states where medical marijuana has been legalized, research conducted on the costs of Medicare prescriptions indicates a whooping $165 million dollar savings in cost prescription drug in the year of 2013. The research clearly shows that medical marijuana reduces the sale and use of prescription and this does not augur well for major pharmaceuticals that earn excessive profits from anesthetics, sedatives, antidepressants and many other categories that medical marijuana currently caters to.  Not surprisingly, states in which marijuana is legalized are beginning to experience a sharp decline in the sales and revenue of prescription drugs like antidepressants, anxiety medication, nausea medications, and sedatives and so on.

Major pharmaceutical companies continue to fund and support the anti- medical marijuana legislation in the bid to keep profits up, despite the fact that medical marijuana offers safer and cheaper alternatives as opposed to the crippling side effects and dependency that is associated with prescription drugs. Very recently, a major pharmaceutical donated the sum of $500,000 to Arizona for Responsible Drug Policy, in a covert attempt to ensure the criminalization of medical marijuana under the pretext of “safety for Arizona citizens, particularly its children”. This and many more campaigns are some of the many attempts by major pharmaceuticals to prevent the widespread legalization of medical marijuana in other to maintain profit margins and promote their selfish interests. Ironically, painkillers pharmaceutical companies that produce some of the deadliest and most addictive prescriptions medication with statistical records showing its debilitating effects of dependency and alarming concomitant side effects are at the front lines in the fight against the legalization of medical marijuana.

The anti drug coalition of America and many other agencies have been secretly funded by pharmaceutical companies producing painkiller drugs, antidepressant to constantly promote the campaign against the legalization of medical marijuana. Studies have indicated that abuse of antidepressants and painkillers are significantly lesser in states where medical marijuana is legalized as opposed to states in which it is not legalized.

Doctors are incrementally prescribing medical marijuana as an alternative to prescription drugs and this has the potential to dramatically affect earnings of major pharmaceuticals. 26 states of 50 in the United States have a liberal posture on the use of medical marijuana and many other countries are beginning to review legislation in favor of the therapeutic and economic gains medical marijuana offers.

Although the use medical marijuana still faces seemingly insurmountable opposition from profit-oriented pharmaceuticals that constantly manipulate media and lobby legislation in their favor, the benefits and advantages are unarguably evident. Cannabis has radically improved the conditions of many offering a natural alternative to the harmful prescription drugs that are manufactured at the detriment of the masses.